Frontiers in Oncology | Breast Cancer

Original Research

Published on 24 Mar 2025

Predictive model using systemic inflammation markers to assess neoadjuvant chemotherapy efficacy in breast cancer

in Breast Cancer

Yulu Sun
Yinan Guan
Hao Yu
Yin Zhang
Jinqiu Tao
Weijie Zhang
Yongzhong Yao

Frontiers in Oncology

doi 10.3389/fonc.2025.1552802

445 views

Opinion

Accepted on 21 Mar 2025

Lessons from the INSEMA Trial: Is sentinel lymph node biopsy in early-stage breast cancer stepping off the stage?

in Breast Cancer

Xiaoyan Chen
Zhi Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1564689

187 views

Opinion

Published on 21 Mar 2025

Redefining conservative mastectomy: the evolution of surgical techniques

in Breast Cancer

Lorenzo Scardina
Gianluca Franceschini

Frontiers in Oncology

doi 10.3389/fonc.2025.1575095

249 views

Original Research

Published on 21 Mar 2025

De-escalation of regional nodal irradiation fields in pT1-2N1 breast cancer patients after breast conserving surgery: retrospective real-world clinical experience

in Breast Cancer

Ji Hyun Hong
Jin-Ho Song
Kyu-Hye Choi
Shin Woo Kim
Woo-Chan Park
Jieun Lee
Ahwon Lee
Jun Kang
Byung-Ock Choi

Frontiers in Oncology

doi 10.3389/fonc.2025.1484190

258 views

Original Research

Accepted on 19 Mar 2025

Adjuvant systemic therapy in Early Breast Cancer and results of a prospective observational multicenter BRIDE study: patients outcome and adherence to guidelines in cancer clinical practice

in Breast Cancer

Stefania Gori
Alessandra Fabi
Catia Angiolini
Monica Turazza
Piermario Salvini
Gianluigi Ferretti
Elisabetta Cretella
Lorenzo Gianni
Claudia Bighin
Angela Toss

Frontiers in Oncology

doi 10.3389/fonc.2025.1501667

Original Research

Accepted on 19 Mar 2025

Cost-effectiveness of companion BRCA testing and adjuvant olaparib treatment in patients with BRCA mutated high-risk HER2-negative early breast cancer

in Breast Cancer

Silviya Nikolova
Wenkang Ma
Gurdeep Sagoo
Yogesh Punekar
Elizabeth Sheppard

Frontiers in Oncology

doi 10.3389/fonc.2025.1419071

Original Research

Accepted on 18 Mar 2025

Additional prognostic value of the BCT score in ER+HER2-breast cancer patients receiving a 21-gene assay-guided adjuvant treatments

in Breast Cancer

Sung Gwe Ahn
Jonghan Yu
Seung Ho Baek
Yeonjin Kim
Woo Young Kim
Jai Hyun Chung
Soong June Bae
Seok Won Kim
Seok Jin Nam
Gyungyub Gong

Frontiers in Oncology

doi 10.3389/fonc.2025.1517073

Original Research

Accepted on 18 Mar 2025

A nomogram for predicting subsequent liver metastasis in patients with metastatic breast cancer

in Breast Cancer

Xuanchen Liu
Weipeng Zhao
Yongsheng Jia
Li Zhang
Zhongsheng Tong

Frontiers in Oncology

doi 10.3389/fonc.2025.1417858

133 views

Correction

Published on 18 Mar 2025

Corrigendum: The synergistic effects of pyrotinib combined with adriamycin on HER2-positive breast cancer

in Breast Cancer

Chaokun Wang
Shuzhen Deng
Jing Chen
Xiangyun Xu
Xiaochen Hu
Dejiu Kong
Gaofeng Liang
Xiang Yuan
Yuanpei Li
Xinshuai Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1536374

249 views

Review

Accepted on 17 Mar 2025

Relationship between Breast Tissue Involution and Breast Cancer

in Breast Cancer

Wenjing Li
Xian Zhao
Min Lu
Chuanxin Ren
Qinyu Han
Xiangqi Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1420350

129 views

Systematic Review

Published on 17 Mar 2025

How effective is acupuncture in treating hot flashes in breast cancer patients? A systematic review and meta-analysis

in Breast Cancer

Genlan Zhang
Cui Gao
Zining Guo
Wenrui Zhao
Xufang Xu
Huaneng Wen
Yaoxuan Li
Run Lin
Nenggui Xu
Shaoyang Cui

Frontiers in Oncology

doi 10.3389/fonc.2025.1543938

437 views

Original Research

Published on 17 Mar 2025

Effect of subcutaneous fat on long-term survival after surgery for stage I-III breast cancer as determined by computed tomography

in Breast Cancer

Yi-Wen Mao
Hong-Dou Zeng
Ye Fang
Xin-Yao Wu
Ming-Hao Zhang
Cheng-Da Hu
Ya-Xin Zhao

Frontiers in Oncology

doi 10.3389/fonc.2025.1506629

347 views

Original Research

Published on 14 Mar 2025

Higher baseline platelet and preoperative platelets to lymphocytes ratio was associated with a higher incidence of axillary node pathologic complete response after neoadjuvant chemotherapy in HER2-low breast cancer: a retrospective cohort study

in Breast Cancer

Shuai Yang
Guanying Liang
Junyi Sun
Lingbing Yang
Zitong Fu
Wantong Sun
Bo Wei
Abiyasi Nanding
Qin Wang
Shouping Xu

Frontiers in Oncology

doi 10.3389/fonc.2025.1437677

450 views

Original Research

Published on 13 Mar 2025

Utilization of lymph node elastography in the axillary staging of breast cancer

in Breast Cancer

Marek Smolar
Eva Kudelova
Ivana Danova
Vincent Lucansky
Zuzana Dankova
Diana Musova
Marian Grendar
Lenka Nosakova
Peter Uhrik
Marek Samec

Frontiers in Oncology

doi 10.3389/fonc.2025.1478701

402 views

Original Research

Published on 13 Mar 2025

The evolving landscape of genetic biomarkers for immunotherapy in primary and metastatic breast cancer

in Breast Cancer

Liang Jin
Zijian Yang
Wei Tang
Pengli Yu
Rongrong Chen
Yan Xu
Jun Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1522262

256 views

Original Research

Published on 12 Mar 2025

Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b study

in Breast Cancer

Sara M. Tolaney
Komal Jhaveri
Teresa Helsten
Shannon L. Puhalla
Alison Conlin
E. Claire Dees
Muralidhar Beeram
Sonya C. Chapman
Andrew Lithio
Lacey M. Litchfield

Frontiers in Oncology

doi 10.3389/fonc.2025.1555921

789 views